Occurrence of clindamycin-resistant anaerobic bacteria isolated from cultures taken following clindamycin therapy.

Antimicrobial Agents and Chemotherapy
M J Ohm-SmithW K Hadley

Abstract

MICs of clindamycin were determined by the agar dilution method against anaerobic organisms isolated from endometrial cultures in women with pelvic soft tissue infections. Cultures were obtained from 100 women both before and after clindamycin therapy, from 107 women before therapy with clindamycin or another antimicrobial agent or after treatment with an antimicrobial agent other than clindamycin, and from 9 women 1 to 9 weeks after they were discharged from the hospital following clindamycin therapy. Only 5 (0.7%) of 685 isolates tested from women who had not received clindamycin therapy were resistant to clindamycin. From the 100 cultures taken immediately after clindamycin therapy, 57 anaerobic bacteria were isolated from 28 cultures. Of the 40 anaerobic organisms for which MICs of clindamycin were determined, 25 (62.5%) were resistant to clindamycin (MIC greater than or equal to 8 micrograms/ml). The most common organisms isolated after therapy were the anaerobic gram-positive cocci (of which 32 isolates were discovered); of 28 coccal isolates tested, 64% were clindamycin resistant. Four of seven (57%) of the Bacteroides isolates tested, one unidentified gram-positive nonsporing rod, one unidentified gram-negative coccus, ...Continue Reading

References

Jun 15, 1976·American Journal of Obstetrics and Gynecology·M J Ohm, R P Galask
Nov 15, 1975·American Journal of Obstetrics and Gynecology·M J Ohm, R P Galask
Oct 1, 1976·Antimicrobial Agents and Chemotherapy·V L Sutter, S M Finegold
Nov 15, 1975·American Journal of Obstetrics and Gynecology·M J Ohm, R P Galask
Aug 1, 1985·American Journal of Obstetrics and Gynecology·R L SweetM O Robbie
Feb 1, 1972·Antimicrobial Agents and Chemotherapy·W J MartinJ A Washington
Jun 1, 1980·Antimicrobial Agents and Chemotherapy·D KayeK Kaye
Nov 1, 1982·Reviews of Infectious Diseases·V K Dhawan, H Thadepalli
Apr 1, 1980·Antimicrobial Agents and Chemotherapy·W J Brown, P E Waatti
Jan 1, 1982·The Medical Clinics of North America·J L LeFrockR A Prince
Oct 15, 1982·JAMA : the Journal of the American Medical Association·M H YeeC E Davis
Nov 1, 1981·Antimicrobial Agents and Chemotherapy·R D Rolfe, S M Finegold
Dec 1, 1981·The Journal of Antimicrobial Chemotherapy·F P TallyM H Malamy
Dec 1, 1981·The Journal of Antimicrobial Chemotherapy·J F AcarM T Eyquem

❮ Previous
Next ❯

Citations

Sep 8, 2005·Journal of Clinical Microbiology·M N AustinS L Hillier
Feb 11, 1998·Clinical Microbiology Reviews·D A Murdoch
Jan 17, 2013·The Journal of Craniofacial Surgery·Edward H Schaefer, Edward J Caterson

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allergy & Infectious Diseases

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Allergy & Infectious Diseases (ASM)

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.